These emerging therapies , Tirzepatide , represent a groundbreaking advancement in addressing metabolic dysfunction and potentially related conditions . They all are categorized as GLP-1 receptor activators , meaning they to mimic the natural GLP-1 substance , boosting insulin secretion and suppr